EMA asks for checks on all the drugs on the market
The European Medicines Agency asks for precautionary checks on all products to exclude the presence of nitrosamines, the "probably carcinogenic"...
The European Medicines Agency asks for precautionary checks on all products to exclude the presence of nitrosamines, the "probably carcinogenic"...
The 59th AFI Symposium is approaching Bio Chem Srl will be present at the 59th AFI Symposium on 5-6-7 June at Stand 83. Last year during the...
Companies are advised that, from 1 January 2019, the tariffs contained in annex 1 of the D.M. 6 December 2016, concerning the "Update of the current...
Please note that AIFA adheres to the eSmissionMap of the Roadmap from the HMA and that, in accordance with Annex 2 of the HMA eSubmission Roadmap,...
Article. 122 paragraph 1 of Legislative Decree 24 April 2006, n.219 (issued in implementation of Directive 2001/83 / EC and Directive 2003/94 / EC)...
In order to allow this Agency to comply with the requirements of the 2018 Stability Law, in the terms in which it has stipulated that it may enter...
EMA and the European Commission have published a document in support of the pharmaceutical industries in tackling UK's exit from the European Union....
The European Commission has published a review, open to comments until May 22 on the list of ingredients to be included in the labels of medicinal...
It is announced that during the meeting of 19 January 2017, the Commission Scientific Technician (CTS) gave a favorable opinion updating the...
Communication Italian Drug Agency With effect from 2017 it will be implemented a new system that will allow sending Pharmaceutical Companies,...